This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Mitsubishi Tanabe Pharma Corporation, Tanabe Seiyaku Company, Limited. Active years: 1994-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Urawa, JP (1994)
- Mitaka, JP (2006)
- Solana Beach, CA (US) (2010 - 2013)
Company Filing History:

Years Active: 1994-2013
Title: Naoki Sakurai: Innovator in Regenerative Medicine
Introduction
Naoki Sakurai is a prominent inventor based in Solana Beach, CA (US). He has made significant contributions to the field of regenerative medicine, particularly in the treatment of cartilage diseases. With a total of 5 patents to his name, Sakurai's work is paving the way for innovative therapeutic solutions.
Latest Patents
Sakurai's latest patents focus on a composition for the regenerative treatment of cartilage disease. This composition includes a PDE4 inhibitor as an active ingredient, combined with a biocompatible and biodegradable polymer. When formulated into a suitable form for local administration to affected cartilage regions, such as microsphere preparations, this pharmaceutical composition demonstrates excellent efficacy in regenerative treatment.
Career Highlights
Throughout his career, Naoki Sakurai has worked with notable companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Tanabe Seiyaku Company, Limited. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Sakurai has collaborated with esteemed colleagues in his field, including Noriyuki Yanaka and Toshiki Takagi. These partnerships have further enhanced his research and development efforts in regenerative medicine.
Conclusion
Naoki Sakurai's contributions to regenerative medicine through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in the treatment of cartilage diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile